Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

451 public trials 58 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders

NCT02494258

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasm, +4 more
Locations: Local Institution - 101 Gainesville, Florida, United States

Local Institution - 103 Baltimore, Maryland, United States

Local Institution - 102 Houston, Texas, United States

Manchester Royal Infirmary Manchester, United Kingdom

View Trial Details

Completed

Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation

NCT04339101

Conditions: Acute Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

NCT02467270

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations: Emory University Winship Cancer Institute Atlanta, Georgia, United States

Indiana Blood & Marrow Transplantation Indianapolis, Indiana, United States

University of Maryland Medical Center Baltimore, Maryland, United States

Michigan Medicine Ann Arbor, Michigan, United States

View all 86 locations

View Trial Details

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants

NCT06797375

Conditions: Autoimmune Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Nucleus Network Brisbane Brisbane, Queensland, Australia

View Trial Details

Completed

Randomized Controlled Trial Comparing a Conservative Management and Laser Surgery

NCT01220011

Conditions: Anemia, Anemia, Neonatal, Blood and Blood Disorders, +6 more
Locations: Children's Hospital Colorado and Colorado Fetal Care Center Aurora, Colorado, United States

University of MD /Department of Obstetrics, Gynecology & Reproductive Sciences Baltimore, Maryland, United States

Fetal Care Center of Cincinnati, Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

The Ohio State University / OSU Fetal Therapy Program Columbus, Ohio, United States

View Trial Details

Completed

Examining the Experiences of Children With Blood Disorders

NCT04600609

Conditions: Bleeding Disorder, Blood Disease, Cardiovascular Diseases, +11 more
Locations: The University of Texas Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies

NCT05895994

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations: Union Hospital, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Completed

Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation

NCT03159702

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

AI Algorithms to Automate the TMI by VMAT Optimization Using WB-CT/MRI and Synthetic WB-CT - The AuToMI Project

NCT04976205

Conditions: Hematologic Diseases, Hematological Disease, Hemic and Lymphatic Diseases
Locations: IRCCS Humanitas Research Center Rozzano, Milano, Italy

View Trial Details

Completed

A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.

NCT05228470

Conditions: BCMA, BCMA-CD3 Bispecific, Bispecific, +23 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View all 15 locations

View Trial Details